The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

ATHX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.03%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Athersys Insider Trading History Chart

Athersys Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Athersys Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2022	Daniel A Camardo	CEO	Buy	132,800	$0.77	$102,256.00
11/19/2021	Ismail Kola	Director	Buy	85,000	$0.96	$81,600.00
11/17/2021	Ivor Macleod	CFO	Buy	15,000	$1.18	$17,700.00
9/20/2021	William Lehmann, Jr.	CEO	Sell	30,000	$1.41	$42,300.00
9/15/2021	John J. Harrington	EVP	Sell	21,050	$1.46	$30,733.00
6/15/2021	John J. Harrington	EVP	Sell	20,767	$1.55	$32,188.85	805,728
6/8/2021	John J. Harrington	EVP	Sell	27,107	$1.75	$47,437.25

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Athersys (NASDAQ:ATHX)

19.35% of Athersys stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Athersys Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Armistice Capital LLC	383,000	$0.17M	0.0%	-80.3%	1.702%
8/2/2023	Values First Advisors Inc.	113,140	$98K	0.1%	+599.6%	0.613%
7/24/2023	Vahanian & Associates Financial Planning Inc.	841,430	$0.73M	2.3%	+2.8%	4.561%
4/27/2023	Simplicity Solutions LLC	31,395	$39K	0.0%	N/A	0.170%
4/18/2023	Vahanian & Associates Financial Planning Inc.	818,350	$1.01M	2.8%	+63.1%	4.436%
2/1/2023	Vahanian & Associates Financial Planning Inc.	501,690	$0.42M	1.4%	+125.9%	4.561%
12/2/2022	Values First Advisors Inc.	15,833	$29K	0.0%	-95.9%	0.144%
11/3/2022	Vahanian & Associates Financial Planning Inc.	222,104	$0.41M	1.4%	-95.9%	2.019%
10/14/2022	Green Alpha Advisors LLC	24,872	$46K	0.0%	-96.6%	0.226%
8/8/2022	Eqis Capital Management Inc.	123,990	$32K	0.0%	+605.9%	0.047%
7/27/2022	Vahanian & Associates Financial Planning Inc.	5,384,257	$1.40M	6.0%	+39.1%	2.040%
7/22/2022	Sequoia Financial Advisors LLC	223,407	$56K	0.0%	+44.8%	0.085%
7/19/2022	MAI Capital Management	1,823,463	$0.47M	0.0%	+1,061.5%	0.691%
7/8/2022	Green Alpha Advisors LLC	733,487	$0.19M	0.0%	+232.6%	0.278%
5/12/2022	Jacob Asset Management of New York LLC	650,000	$0.39M	0.2%	-20.7%	0.258%
5/11/2022	GSA Capital Partners LLP	590,294	$0.36M	0.0%	+5.8%	0.235%
5/9/2022	Tobias Financial Advisors Inc.	60,000	$36K	0.0%	N/A	0.024%
5/3/2022	Values First Advisors Inc.	347,876	$0.21M	0.1%	+32.1%	0.143%
4/27/2022	Vahanian & Associates Financial Planning Inc.	3,871,602	$2.34M	5.4%	-24.4%	1.587%
4/19/2022	Graypoint LLC	2,117,497	$1.28M	0.1%	N/A	0.868%
4/19/2022	Green Alpha Advisors LLC	220,503	$0.13M	0.1%	+11.7%	0.090%
3/10/2022	Values First Advisors Inc.	263,405	$0.24M	0.1%	N/A	0.112%
2/14/2022	GSA Capital Partners LLP	557,964	$0.50M	0.1%	+109.8%	0.237%
2/10/2022	Perkins Capital Management Inc.	59,000	$53K	0.0%	+151.1%	0.025%
2/9/2022	Wealth Effects LLC	71,500	$65K	0.0%	N/A	0.030%
2/8/2022	ProShare Advisors LLC	44,739	$40K	0.0%	+70.5%	0.019%
2/8/2022	Northern Trust Corp	1,871,334	$1.69M	0.0%	-8.9%	0.796%
2/7/2022	Claraphi Advisory Network LLC	34,000	$31K	0.0%	+47.8%	0.014%
2/7/2022	SG Americas Securities LLC	32,028	$29K	0.0%	-64.1%	0.014%
2/4/2022	Envestnet Asset Management Inc.	46,490	$42K	0.0%	+32.4%	0.020%
1/31/2022	Commonwealth Equity Services LLC	58,784	$53K	0.0%	-22.9%	0.025%
1/28/2022	Vahanian & Associates Financial Planning Inc.	5,122,682	$4.62M	3.7%	N/A	2.178%
1/28/2022	Newport Capital Group LLC	100,246	$90K	0.1%	N/A	0.043%
1/27/2022	Cedar Brook Financial Partners LLC	206,435	$0.19M	0.0%	+13.8%	0.088%
11/16/2021	Metropolitan Life Insurance Co NY	58,535	$78K	0.0%	N/A	0.026%
11/15/2021	GSA Capital Partners LLP	265,894	$0.35M	0.0%	+2,385.0%	0.118%
11/12/2021	Jacob Asset Management of New York LLC	820,000	$1.09M	0.4%	+13.9%	0.362%
11/12/2021	Geode Capital Management LLC	3,693,055	$4.91M	0.0%	+6.9%	1.632%
11/10/2021	Goldman Sachs Group Inc.	203,558	$0.27M	0.0%	-56.6%	0.090%
11/10/2021	Citigroup Inc.	28,002	$37K	0.0%	+113.3%	0.012%
11/9/2021	Barclays PLC	95,467	$0.13M	0.0%	+34.1%	0.042%
11/9/2021	BlackRock Inc.	14,500,588	$19.29M	0.0%	+1.6%	6.409%
11/9/2021	Principal Financial Group Inc.	40,686	$54K	0.0%	+31.7%	0.018%
11/8/2021	Swiss National Bank	441,700	$0.59M	0.0%	+2.9%	0.195%
11/2/2021	Cambridge Investment Research Advisors Inc.	90,021	$0.12M	0.0%	+12.1%	0.040%
11/1/2021	Cedar Brook Financial Partners LLC	181,435	$0.24M	0.1%	-7.6%	0.080%
11/1/2021	SG Americas Securities LLC	89,321	$0.12M	0.0%	N/A	0.039%
10/26/2021	Sequoia Financial Advisors LLC	181,000	$0.24M	0.0%	+28.4%	0.080%
10/25/2021	Cerity Partners LLC	54,000	$72K	0.0%	N/A	0.024%
10/15/2021	NEXT Financial Group Inc	248,200	$0.33M	0.0%	-13.2%	0.110%
10/14/2021	Private Advisor Group LLC	29,860	$41K	0.0%	N/A	0.013%
10/14/2021	Livingston Group Asset Management CO operating as Southport Capital Management	39,380	$52K	0.0%	-51.5%	0.017%
10/12/2021	Green Alpha Advisors LLC	191,242	$0.25M	0.2%	+7.6%	0.085%
9/17/2021	Virtu Financial LLC	34,625	$50K	0.0%	N/A	0.015%
8/17/2021	Millennium Management LLC	1,002,826	$1.44M	0.0%	N/A	0.443%
8/17/2021	Balyasny Asset Management LLC	116,120	$0.17M	0.0%	N/A	0.051%
8/16/2021	Squarepoint Ops LLC	93,422	$0.14M	0.0%	-73.2%	0.041%
8/16/2021	Amalgamated Bank	36,608	$53K	0.0%	+36.0%	0.016%
8/16/2021	UBS Asset Management Americas Inc.	152,508	$0.22M	0.0%	+10.3%	0.067%
8/16/2021	California State Teachers Retirement System	277,727	$0.40M	0.0%	+6.2%	0.123%
8/16/2021	Credit Suisse AG	159,755	$0.23M	0.0%	+17.5%	0.071%
8/16/2021	Charles Schwab Investment Management Inc.	492,924	$0.71M	0.0%	+13.3%	0.218%
8/16/2021	State Street Corp	3,633,078	$5.23M	0.0%	-70.7%	1.606%
8/16/2021	Goldman Sachs Group Inc.	469,363	$0.68M	0.0%	+249.9%	0.207%
8/13/2021	Alpine Global Management LLC	18,393	$26K	0.0%	N/A	0.008%
8/13/2021	Northern Trust Corp	2,089,843	$3.01M	0.0%	+7.7%	0.924%
8/13/2021	Natixis	35,000	$53K	0.0%	N/A	0.015%
8/13/2021	Qube Research & Technologies Ltd	160,708	$0.23M	0.0%	N/A	0.071%
8/13/2021	Geode Capital Management LLC	3,454,380	$4.97M	0.0%	+12.8%	1.527%
8/13/2021	Vanguard Group Inc.	9,844,531	$14.18M	0.0%	-1.5%	4.351%
8/12/2021	XTX Topco Ltd	17,787	$26K	0.0%	N/A	0.008%
8/12/2021	JPMorgan Chase & Co.	3,809,839	$5.49M	0.0%	+12.5%	1.684%
8/12/2021	Boston Family Office LLC	24,000	$35K	0.0%	-45.0%	0.011%
8/12/2021	The Manufacturers Life Insurance Company	130,803	$0.19M	0.0%	+23.9%	0.058%
8/12/2021	Eqis Capital Management Inc.	19,598	$28K	0.0%	N/A	0.009%
8/11/2021	Bank of New York Mellon Corp	656,786	$0.95M	0.0%	-8.9%	0.290%
8/11/2021	BlackRock Inc.	14,277,137	$20.56M	0.0%	+1.0%	6.310%
8/11/2021	Deutsche Bank AG	127,606	$0.18M	0.0%	+5.6%	0.056%
8/10/2021	Mercer Global Advisors Inc. ADV	40,899	$59K	0.0%	+23.2%	0.018%
8/10/2021	Principal Financial Group Inc.	30,888	$44K	0.0%	-18.9%	0.014%
8/10/2021	Cambridge Investment Research Advisors Inc.	80,337	$0.12M	0.0%	+10.2%	0.036%
8/6/2021	Nisa Investment Advisors LLC	43,450	$63K	0.0%	N/A	0.019%
8/2/2021	Advisor Group Holdings Inc.	125,238	$0.18M	0.0%	+8.9%	0.055%
7/31/2021	Green Alpha Advisors LLC	177,808	$0.26M	0.2%	N/A	0.079%
7/31/2021	Strategic Wealth Designers	40,130	$58K	0.0%	+20.4%	0.018%
7/31/2021	NEXT Financial Group Inc	285,800	$0.41M	0.0%	+5.2%	0.126%
7/30/2021	Alliancebernstein L.P.	196,600	$0.28M	0.0%	+16.3%	0.087%
7/12/2021	Gradient Investments LLC	35,000	$50K	0.0%	+40.0%	0.015%
5/19/2021	Squarepoint Ops LLC	347,972	$0.63M	0.0%	+2,769.9%	0.157%
5/17/2021	AQR Capital Management LLC	48,342	$87K	0.0%	-37.5%	0.022%
5/17/2021	Royal Bank of Canada	15,357	$28K	0.0%	+1,583.9%	0.007%
5/17/2021	Price T Rowe Associates Inc. MD	146,635	$0.26M	0.0%	-9.1%	0.066%
5/17/2021	Captrust Financial Advisors	37,000	$67K	0.0%	-20.1%	0.017%
5/17/2021	Nuveen Asset Management LLC	631,198	$1.14M	0.0%	-2.8%	0.284%
5/17/2021	Goldman Sachs Group Inc.	134,149	$0.24M	0.0%	-32.3%	0.060%
5/14/2021	Algert Global LLC	26,890	$48K	0.0%	N/A	0.012%
5/14/2021	Credit Suisse AG	135,944	$0.24M	0.0%	-58.3%	0.061%
5/13/2021	SG Americas Securities LLC	30,090	$54K	0.0%	+83.3%	0.014%
5/13/2021	Barclays PLC	146,121	$0.26M	0.0%	+65.4%	0.066%
5/13/2021	Renaissance Technologies LLC	265,804	$0.48M	0.0%	N/A	0.120%

Data available starting January 2016

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.

Today's Range

Now: $0.00

$0.00

$0.01

50 Day Range

MA: $0.01

$0.00

$0.02

52 Week Range

Now: $0.00

$0.01

$1.99

Volume

396,725 shs

Average Volume

1,765,480 shs

Market Capitalization

$290,079.30

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.